Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Psychopharmacology|January 1, 1991
Effects of loprazolam on cognitive functionsS R Bareggi, L Ferini-Strambi, R Pirola, et al.
Clinical Neuropharmacology|January 1, 1990
Factors affecting the clinical response to haloperidol therapy in schizophreniaS R Bareggi, M Mauri, R Cavallaro, et al.
European Journal of Clinical Pharmacology|January 1, 1988
Pharmacokinetics and bioavailability of intravenous and oral chlordesmethyldiazepam in humansS R Bareggi, G Truci, S Leva, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 9, 2002
Determination of sodium 3,4-diaminonaphthalene-1-sulfonate, a Congo Red derivative, in plasma and brain of hamsters by high-performance liquid chromatography after solid-phase extraction and ultraviolet absorbanceR Pirola, M Gervasoni, C Pollera, et al.
Neuropharmacology|September 1, 1987
Effect of a cholecystokinin antagonist on some effects of diazepamA E Panerai, L C Rovati, M Bianchi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1975
Monoamine acid metabolites and cerebrospinal fluid dynamics in normal pressure hydrocephalus: preliminary resultsG Maira, S R Bareggi, C Di Rocco, et al.
International Journal of Clinical Pharmacology Research|January 1, 1986
Age-related multiple-dose pharmacokinetics and anxiolytic effects of delorazepam (chlordesmethyldiazepam)S R Bareggi, N P Nielsen, S Leva, et al.
Journal of Neuroscience Research|January 1, 1975
3-Methoxy-4-hydroxy-phenylglycol sulfate (MOPEG-SO4) in ventricular and cisternal cerebrospinal fluid of dogsS R Bareggi, J R Stabenau, E G Shaskan, et al.
Acta Neurochirurgica|January 1, 1976
Monoamine acid metabolites in ventricular CSF of patients with brain tumoursS R Bareggi, M Porta, M Collice, et al.
Pageof 6